1. Sonoo H, Kurebayashi J: Endocrine therapy for breast cancer.Rinsho-to-Kenkyu 74:822–828, 1997 (in Japanese).
2. The Japanese Breast Cancer Society: Criteria for the evaluation of efficacy of therapies in advanced and recurrent breast cancer patients. In: the Japanese Breast Cancer Society eds, General Rules for Clinical and Pathological Recording of Breast Cancer, 12th ed, Kanehara Publisher, Tokyo, pp57–68, 1996 (in Japanese).
3. Klijn JGM, Seynaeve C, Beex L,et al: Combined treatment of buserelin (LHRH-A) and tamoxifen (TAM) us single treatment with each drug alone in premenopausal metastatic breast cancer; Preliminary results of EORTC study 10881.ProcASCO 15:117, 1996.
4. Jonat W: Luteinizing hormone-releasing hormone analogues; The rationale for adjuvant use in premenopausal women with early breast cancer.Br J Cancer 78:5–8, 1998.
5. Lonning PE: Aromatase inhibitors and their future role in post-menopausal women with early breast cancer.Br J Cancer 78:12–15, 1998.